Home › Funds › Patient Square Capital LP › ELVN

Patient Square Capital LP position in ELVN

ENLIVEN THERAPEUTICS INC · Health Care

Patient Square Capital LP reported holding 212,500 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.7M, representing 1.55% of its reported portfolio and ranking #17 among its reported holdings. Patient Square Capital LP has disclosed ELVN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)212.50K sh
Reported value held$9.74M
Portfolio Weight1.55%
First reportedQ3 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Patient Square Capital LP's ELVN position evolved

Patient Square Capital LP first disclosed a stake in ELVN in Q3 2024 at 90,572 shares (US$2.3M). The position peaked in Q2 2026 at 212,500 shares, worth US$10.8M. Across 9 filings, Patient Square Capital LP increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 212,500 shares valued at US$9.7M. Notable position changes include a 147% increase in Q4 2024 (shares fell 13% over the following quarter), a 35% trim in Q1 2026 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 90.57K $2.31M New
Q4 2024 224.04K $5.04M Add
Q1 2025 253.84K $5.00M Add
Q2 2025 245.84K $4.93M Reduce
Q3 2025 250.84K $5.13M Add
Q4 2025 308.14K $4.75M Add
Q1 2026 200.00K $7.84M Reduce
Q2 2026 212.50K $10.78M Add
Q3 2026 212.50K $9.74M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELVN and 13F data

ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 67 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$343.9M), Polar Capital Holdings Plc (US$326.4M), Vestal Point Capital, LP (US$203.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELVN

All ELVN fund holders →

FAQ

How long has Patient Square Capital LP held ELVN?

Patient Square Capital LP has disclosed ELVN holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Patient Square Capital LP's current position in ELVN?

As of Q3 2026, Patient Square Capital LP holds 212.50K shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $9.74M, representing 1.55% of its reported portfolio and ranking #17.

Has Patient Square Capital LP been buying or selling ELVN?

In the latest 13F filing (Q3 2026), Patient Square Capital LP held unchanged its position in ELVN. The position peaked in Q2 2026 at 212.50K shares.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Vestal Point Capital, LP, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.